In November 2013, it was announced that the GraftCraft project Unravelling Stent will receive the VINN Verifiering grant from VINNOVA, the Swedish Innovation Agency.
– We are very thankful to get this support from VINNOVA, says CEO Erney Mattsson. This further indicates that our project has importance for our societies, clinical strength and commercial opportunities.
The VINN project will continue for two years, preparing the Unravelling Stent for clinical studies in human and developing the commercial strategy. The project and its milestones are monitored and evaluated by VINNOVA semi-annually.
VINNOVA is the Swedish innovation agency, working to strengthen Sweden’s innovativeness by investing time, capital and support into innovative companies and startups. Except for the VINN Verifiering grant, a number of grants is each year given to small companies and research groups to help them grow and develop their innovations further. VINNOVA is also the Swedish agency working towards the European Union regarding Horizon 2020.
For more information regarding the VINNOVA grant, see http://www.vinnova.se/sv/Resultat/Projekt/Effekta/Unravelling-Stent/
or contact project manager Emma Wejedal: firstname.lastname@example.org